Impact of the Use of Proton Pump Inhibitors on Pembrolizumab Effectiveness for Advanced Urothelial Carcinoma. Tomisaki I, Harada M, Minato A, Nagata Y, et al. Anticancer Res 2022;42:1629-1634.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tomisaki I, Harada M, Minato A, Nagata Y, et al. Impact of the Use of Proton Pump Inhibitors on Pembrolizumab Effectiveness for Advanced Urothelial Carcinoma. Anticancer Res 2022;42:1629-1634.
PMID: 35220261